| Pharmaceutical active ingredients: |
| BendroflumethiazideReserpine |
| Available forms, composition and doses of Tensionorme: |
| Tablets; Oral; Bendroflumethiazide 2.5 mg; Reserpine 0.1 mg |
| Tensionorme medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02LA01 - Reserpine and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Lisapharm Laboratoire |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dociretic | Bendroflumethiazide; Propranolol Hydrochloride | AstraZeneca; Mibe Arzneimittel |
| Inderetic | Bendroflumethiazide; Propranolol Hydrochloride | AstraZeneca |
| Inderex | Bendroflumethiazide; Propranolol Hydrochloride | AstraZeneca |
| Rauzide | Bendroflumethiazide; Rauwolfia Serpentina | Bristol-Myers Squibb; Apothecon |
| Abicol | Bendroflumethiazide; Reserpine | Boots |
| Sali-Aldopur | Bendroflumethiazide; Spironolactone | Hormosan Pharma; F. Joh. Kwizda |
| Sali-Aldopur Forte | Bendroflumethiazide; Spironolactone | Hormosan Pharma; F. Joh. Kwizda |
| Saluretin | Bendroflumethiazide; Spironolactone | AstraZeneca |
| Spirometon | Bendroflumethiazide; Spironolactone | Belmac Laboratorios |
| Spirostada Comp. | Bendroflumethiazide; Spironolactone | Stada |